Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 6/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.46 |
| ▸ | HRH2 | P25021 | 6/20 | 0.37 |
| ▸ | HRH1 | P35367 | 6/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2894873 | 1.00 | GPR119 (0.46) | GPR119KCNH2HRH2HRH1HRH3 | |
| SCHEMBL2894865 | 1.00 | GPR119 (0.46) | GPR119KCNH2HRH2HRH1HRH3 | |
| SCHEMBL2891044 | 0.96 | GPR119 (0.47) | GPR119KCNH2HRH2HRH1HRH3 | |
| SCHEMBL2891048 | 0.96 | GPR119 (0.47) | GPR119KCNH2HRH2HRH1HRH3 | |
| SCHEMBL2897197 | 0.92 | GPR119 (0.48) | GPR119KCNH2HRH2HRH1HRH3 | |
| SCHEMBL2890673 | 0.90 | GPR119 (0.48) | GPR119KCNH2HRH3 | |
| SCHEMBL2899111 | 0.90 | GPR119 (0.48) | GPR119KCNH2HRH3 | |
| SCHEMBL2890667 | 0.90 | GPR119 (0.48) | GPR119KCNH2HRH3 | |
| SCHEMBL2895540 | 0.89 | GPR119 (0.49) | GPR119KCNH2HRH2HRH1HRH3 | |
| SCHEMBL2897187 | 0.89 | GPR119 (0.49) | GPR119KCNH2HRH2HRH1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2200609-A1 | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | Prosidion Limited (GB) | 2010-06-30 | — | — | EP | disclosed |
| WO-2009034388-A1 | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | PROSIDION LIMITED (GB) | 2009-03-19 | — | — | WO | disclosed |